Trifluoroacetic acid → HCID 178429072, compound
Reaction equation
[C:1]([C:4]1[N:9]=[CH:8][C:7]([NH:10][C@@H:11]2[CH2:16][CH2:15][CH2:14][CH2:13][C@@H:12]2[NH:17][C:18](=[O:24])[O:19]C(C)(C)C)=[CH:6][C:5]=1[NH:25][C:26]1[CH:31]=[C:30]([OH:32])[CH:29]=[C:28]([CH3:33])[N:27]=1)(=[O:3])[NH2:2].C(O)(C(F)(F)F)=O>C(Cl)Cl>[CH:18]([OH:24])=[O:19].[NH2:17][C@H:12]1[CH2:13][CH2:14][CH2:15][CH2:16][C@H:11]1[NH:10][C:7]1[CH:6]=[C:5]([NH:25][C:26]2[CH:31]=[C:30]([OH:32])[CH:29]=[C:28]([CH3:33])[N:27]=2)[C:4]([C:1]([NH2:2])=[O:3])=[N:9][CH:8]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of tert-butyl [(1S,2R)-2-({6-carbamoyl-5-[(4-hydroxy-6-methylpyridin-2-yl)amino]pyridin-3-yl]amino)cyclohexyl}carbamate (32 mg, 0.070 mmol) in DCM (2 ml) was added TFA (1.0 mL, 13 mmol), and the reaction mixture was stirred for 30 minutes at ambient temperature. The reaction mixture was concentrated under reduced pressure, dissolved in DMSO (1 mL), and purified by reverse phase HPLC (acetonitrile/water with 0.1% formic acid, linear gradient) to afford 5-{[(1R,2S)-2-aminocyclohexyl]amino}-3-[(4-hydroxy-6-methylpyridin-2-yl)amino]pyridine-2-carboxamide formic acid salt. MS ESI calc'd. for C18H25N6O2 [M+H]+ 357. found 357. 1H NMR (500 MHz, CD3OD) δ 8.10 (s, 1H), 7.85 (s, 1H), 7.40 (s, 1H), 6.39 (s, 1H), 6.25 (s, 1H), 3.95 (br s, 1H), 3.56 (br s, 1H), 2.38 (s, 3H), 1.90-1.82 (m, 3H), 1.80-1.62 (m, 3H), 1.60-1.50 (m, 2H).
Workup
- concentrationThe reaction mixture was concentrated under reduced pressure
- dissolutiondissolved in DMSO (1 mL)
- custompurified by reverse phase HPLC (acetonitrile/water with 0.1% formic acid, linear gradient)
Sources & evidence
- ORD record
- ord-1cf0ae99d20a4fffac283055058eb74e
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09216173B2
Reaction notes
Loading…